Literature DB >> 28599453

TUC338 promotes cell migration and invasion by targeting TIMP1 in cervical cancer.

Qin Li1, Feiyang Shen2, Chenghai Wang3,4,5.   

Abstract

Ultraconserved regions (UCRs) are non-protein-coding gene sequences that are strictly conserved across numerous distinct species. It has been demonstrated previously that UCRs encoding non-coding RNAs serve as regulators of gene expression. In recent decades, there has been increasing evidence for the involvement of UCRs in carcinogenesis. In previous studies, the non-coding RNA transcribed ultraconserved element 338 (TUC338) was identified to serve an oncogenic role in hepatocellular cancer; however, thus far, the role of TUC338 in cervical cancer (CC) remains undefined. The results of the present study revealed that TUC338 is significantly upregulated in CC tissues and cell lines, and that the upregulation of TUC338 is associated with lymph node metastasis. Transfection with small interfering RNA (siRNA) against TUC338 could markedly inhibit cell migration and invasion in HeLa and C33A CC cell lines. Using a dual-luciferase reporter assay, tissue inhibitor of metalloproteinase 1 (TIMP1) was demonstrated to be negatively regulated by TUC338 at the post-transcriptional level, via a specific target site within the 3' untranslated region. The expression of TIMP1 was also observed to be inversely associated with TUC338 expression in CC tissues. Overexpression of TIMP1 with MigRI-TIMP1-green fluorescent protein inhibited CC cell migration and invasion and downregulated matrix metalloproteinase 9, resembling the effects of TUC338 siRNA. Therefore, the results of the present study suggest that TUC338 acts as a novel oncogene by targeting the TIMP1 gene, and inhibiting CC cell migration and invasion.

Entities:  

Keywords:  cervical cancer; invasion; matrix metalloproteinase 9; migration; tissue inhibitor of metalloproteinase 1; transcribed ultraconserved element 338

Year:  2017        PMID: 28599453      PMCID: PMC5453013          DOI: 10.3892/ol.2017.5971

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A distal enhancer and an ultraconserved exon are derived from a novel retroposon.

Authors:  Gill Bejerano; Craig B Lowe; Nadav Ahituv; Bryan King; Adam Siepel; Sofie R Salama; Edward M Rubin; W James Kent; David Haussler
Journal:  Nature       Date:  2006-04-16       Impact factor: 49.962

3.  Cancer. The metastasis cascade.

Authors:  Christoph A Klein
Journal:  Science       Date:  2008-09-26       Impact factor: 47.728

4.  An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours.

Authors:  P Mestdagh; E Fredlund; F Pattyn; A Rihani; T Van Maerken; J Vermeulen; C Kumps; B Menten; K De Preter; A Schramm; J Schulte; R Noguera; G Schleiermacher; I Janoueix-Lerosey; G Laureys; R Powel; D Nittner; J-C Marine; M Ringnér; F Speleman; J Vandesompele
Journal:  Oncogene       Date:  2010-04-12       Impact factor: 9.867

5.  Tumor size and lymph node status determined by imaging are reliable factors for predicting advanced cervical cancer prognosis.

Authors:  Min Sun Kyung; Hong Bae Kim; Jung Yeob Seoung; In Young Choi; Young Soo Joo; Me Yeon Lee; Jung Bae Kang; Young Han Park
Journal:  Oncol Lett       Date:  2015-03-05       Impact factor: 2.967

6.  Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.

Authors:  Wioletta Pietruszewska; Katarzyna Bojanowska-Poźniak; Józef Kobos
Journal:  Otolaryngol Pol       Date:  2016-06-30

7.  Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma.

Authors:  Jun Ma; Jun Wang; Weifei Fan; Xiaolin Pu; Dawei Zhang; Chou Fan; Lin Xiong; Huijun Zhu; Ning Xu; Renjie Chen; Shaofeng Liu
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

8.  Human genome ultraconserved elements are ultraselected.

Authors:  Sol Katzman; Andrew D Kern; Gill Bejerano; Ginger Fewell; Lucinda Fulton; Richard K Wilson; Sofie R Salama; David Haussler
Journal:  Science       Date:  2007-08-17       Impact factor: 47.728

9.  MicroRNA Control of Invasion and Metastasis Pathways.

Authors:  Rahul Sreekumar; Berna S Sayan; Alex H Mirnezami; A Emre Sayan
Journal:  Front Genet       Date:  2011-09-05       Impact factor: 4.599

10.  Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.

Authors:  Antonietta Rosella Farina; Andrew Reay Mackay
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

View more
  8 in total

1.  Role of the tumour protein P53 gene in human cervical squamous carcinoma cells: Discussing haematopoietic cell-specific protein 1-associated protein X-1-induced survival, migration and proliferation.

Authors:  Bing Qian; Li-Jun Zhao; Fang Teng; Ling-Juan Gao; Rong Shen
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

2.  A novel lncRNA derived from an ultraconserved region: lnc-uc.147, a potential biomarker in luminal A breast cancer.

Authors:  Erika Pereira Zambalde; Recep Bayraktar; Tayana Schultz Jucoski; Cristina Ivan; Ana Carolina Rodrigues; Carolina Mathias; Erik Knutsen; Rubens Silveira de Lima; Daniela Fiori Gradia; Enilze Maria de Souza Fonseca Ribeiro; Samir Hannash; George Adrian Calin; Jaqueline Carvalhode Oliveira
Journal:  RNA Biol       Date:  2021-08-13       Impact factor: 4.766

3.  Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.

Authors:  WenQian Zhang; Wei Sun; Yuan Qin; CangHao Wu; Liang He; Ting Zhang; Liang Shao; Hao Zhang; Ping Zhang
Journal:  J Cell Mol Med       Date:  2019-06-18       Impact factor: 5.310

4.  TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway.

Authors:  Yan Li; Zhenwei Jia; Hongbo Zhao; Xiaoyan Liu; Jianmin Luo; Guirong Cui; Xiaoyang Kong
Journal:  J Oncol       Date:  2021-04-19       Impact factor: 4.375

5.  Overexpression of the transcribed ultraconserved region Uc.138 accelerates colon cancer progression.

Authors:  Yuki Kuwano; Kensei Nishida; Kazuhito Rokutan
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

6.  Silencing of long non-coding RNA TUC338 inhibits the malignant phenotype of nasopharyngeal cancer cells via modulating the miR-1226-3p/FGF2 axis.

Authors:  Jian Wang; Liping Li; Xue Jiang; Bin Wang; Xiaodong Hu; Weiwei Liu; Ying Zhang
Journal:  Discov Oncol       Date:  2022-10-12

7.  Knockdown of lncRNA TUC338 inhibits esophageal cancer cells migration and invasion.

Authors:  Ting Qian; Hui Zhang; Shaorong Yu; Zhenzhang Chen; Hui Jia; Fanyu Peng; Guochun Cao; Jianwei Lu; Delin Liu; Dawei Sun
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

8.  Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.

Authors:  Gong-Peng Dai; Li-Ping Wang; Yu-Qing Wen; Xue-Qun Ren; Shu-Guang Zuo
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.